Biodegradable nanoparticles for gene therapy technology
Source abstract
Abstract
Rapid propagations in materials technology together with biology have initiated great hopes in the possibility of treating many diseases by gene therapy technology. Viral and non-viral gene carriers are currently applied for gene delivery. Non-viral technology is safe and effective for the delivery of genetic materials to cells and tissues. Non-viral systems are based on plasmid expression containing a gene encoding a therapeutic protein and synthetic biodegradable nanoparticles as a safe carrier of gene. Biodegradable nanoparticles have shown great interest in drug and gene delivery systems as they are easy to be synthesized and have no side effect in cells and tissues. This review provides a critical view of applications of biodegradable nanoparticles on gene therapy technology to enhance the localization of in vitro and in vivo and improve the function of administered genes.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Animal Virus Infections Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Abdullah S, Yeo WY, Hosseinkhani H, Hosseinkhani M, Masrawa E, Ramasamy R, Rosli R, Rahman SA, Domb AJ (2010) Gene transfer into the lung by nanoparticle dextran–spermine/plasmid DNA complexes. J Biomed Biotechnol 2010:1–1010.1155/2010/284840 ↗
2. Abedini F, Ismail M, Hosseinkhani H, Azmi T, Omar A, PeiPei C, Ismail N, Farber IY, Domb AJ (2010) Toxicity evaluation of dextran–spermine polycation as a tool for gene therapy in vitro. J Cell Animal Biol 4:170–176
3. Abedini F, Hosseinkhani H, Ismail M, Chen YR, Omar AR, Pei Pei C, Domb AJ (2011a) In vitro intracellular trafficking of biodegradable nanoparticles of dextran–spermine in cancer cell lines. Int J Nanotechnol 8:712–72310.1504/IJNT.2011.041440 ↗
4. Abedini F, Ismail M, Hosseinkhani H, Ibrahim TA, Omar AR, Chong PP, Bejo MH, Domb AJ (2011b) Effects of CXCR4 siRNA/dextran–spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. Cancer Manag Res 3:301–309
5. Abedini F, Hosseinkhani H, Ismail M, Domb AJ, Omar AR, Pei Pei C, Hong PD, Yu DS, Farber IV (2012) Cationized dextran nanoparticles-encapsulated CXCR4–siRNA enhanced correlation between CXCR4 expression and serum ALP in colorectal cancer. Int J Nanomed 7:4159–4168
6. Amini R, Hosseinkhani H, Jalilian A, Abdullah S, Rosli R (2012) Engineered smart biomaterials for gene delivery. Gene Ther Mol Biol 14:72–86
7. Aoyama T, Hosseinkhani H, Yamamoto S, Ogawa O, Tabata Y (2002) Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle. J Control Release 80:345–35610.1016/S0168-3659(02)00029-9 ↗
8. Atkins RL, Wang D, Burke RD (2000) Localized electroporation: a method for targeting expression of genes in avian embryos. Biotechniques 28:94–96, 98, 10010.2144/00281st04 ↗
9. Banan M, Puri N (2004) The ins and outs of RNAi in mammalian cells. Curr Pharm Biotechnol 5:441–45010.2174/1389201043376643 ↗
10. Breunig M, Lungwitz U, Liebl R, Fontanari C, Klar J, Kurtz A, Blunk T, Goepferich A (2005) Gene delivery with low molecular weight linear polyethylenimines. J Gene Med 7:1287–129810.1002/jgm.775 ↗
11. Chandy T, Sharma CP (1990) Chitosan: as a Biomaterial. Biomater Artif Cells Artif Organs 18:1–2410.3109/10731199009117286 ↗
12. Chen TH, Yeh CT, Ho YP, Hsu CM, Huang CC, Shiau SS, Liang CK, Chang ML (2009) Hydrodynamics-based transfection of pancreatic duodenal homeobox 1 DNA improves hyperglycemia and is associated with limited complications in diabetic mice. Endocr J 56:783–79010.1507/endocrj.K09E-112 ↗
13. de la Fuente M, Seijo B, Alonso MJ (2008) Novel hyaluronic acid–chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci 49:2016–202410.1167/iovs.07-1077 ↗
14. Elangovan S, Jain S, Tsai PC, Margolis HC, Amiji M (2012) Nano-sized calcium phosphate particles for periodontal gene therapy. J Periodontol 84:117–12510.1902/jop.2012.120012 ↗
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–49810.1038/35078107 ↗
16. Eliyahu H, Joseph A, Schillemans JP, Azzam T, Domb AJ, Barenholz Y (2007) Characterization and in vivo performance of dextran–spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically. Biomaterials 28:2339–234910.1016/j.biomaterials.2006.09.001 ↗
17. Gaucheron J, Santaella C, Vierling P (2002) Transfection with fluorinated lipoplexes based on fluorinated analogues of DOTMA, DMRIE and DPPES. Biochim Biophys Acta 1564:349–35810.1016/S0005-2736(02)00469-8 ↗
18. Hashida M, Takemura S, Nishikawa M, Takakura Y (1998) Targeted delivery of plasmid DNA complexed with galactosylated poly(l-lysine). J Control Release 53:301–31010.1016/S0168-3659(97)00263-0 ↗
19. Hernot S, Klibanov AL (2008) Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60:1153–116610.1016/j.addr.2008.03.005 ↗
20. Hosseinkhani H (2006) DNA nanoparticles for gene delivery to cells and tissue. Int J Nanotechnol 3:416–46110.1504/IJNT.2006.011172 ↗
21. Hosseinkhani H (2011) Editorial: on nanomedicine. Int J Nanotechnol 8:615–617
22. Hosseinkhani H (2012) 3D in vitro technology for drug discovery. Curr Drug Saf 7:37–4310.2174/157488612800492753 ↗
23. Hosseinkhani H, Hosseinkhani M (2008a) Suppression effect of basic fibroblast growth factor on mesenchymal stem cell proliferation activity; part I: release characteristics. Chem Today 26:30–32
24. Hosseinkhani H, Hosseinkhani M (2008b) Suppression effect of basic fibroblast growth factor on mesenchymal stem cell proliferation activity; part II: biological characteristics. Chem Today 26:35–37
25. Hosseinkhani H, Hosseinkhani M (2009) Biodegradable polymer–metal complexes for gene and drug delivery. Curr Drug Saf 4:79–8310.2174/157488609787354477 ↗
26. Hosseinkhani H, Tabata Y (2003) In vitro gene expression by cationized derivatives of an artificial protein with repeated RGD sequences, Pronectin®. J Control Release 86:169–18210.1016/S0168-3659(02)00412-1 ↗
27. Hosseinkhani H, Tabata Y (2004) PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin®. J Control Release 97:157–17110.1016/j.jconrel.2004.02.025 ↗
28. Hosseinkhani H, Tabata Y (2005) Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran. J Control Release 108:540–55610.1016/j.jconrel.2005.08.027 ↗
29. Hosseinkhani H, Tabata Y (2006) Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. J Nanosci Nanotechnol 6:2320–232810.1166/jnn.2006.507 ↗
30. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2001) In vitro transfection of plasmid DNA by different-cationized gelatin with or without ultrasound irradiation. Proc Jpn Acad Ser B 77:161–16610.2183/pjab.77.161 ↗
31. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2002a) Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin. J Drug Target 10:193–20410.1080/10611860290022624 ↗
32. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2002b) In vitro transfection of plasmid DNA by amine derivatives of gelatin accompanied with ultrasound irradiation. Pharm Res 19:1469–147710.1023/A:1020400514990 ↗
33. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2002c) Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination. J Control Release 83:287–30210.1016/S0168-3659(02)00201-8 ↗
34. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2003a) Tumor targeting of gene expression by dextran conjugation based on metal coordination. J Control Release 88:297–31210.1016/S0168-3659(02)00425-X ↗
35. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2003b) Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. Curr Pharm Biotechnol 4:109–12210.2174/1389201033489883 ↗
36. Hosseinkhani H, Azzam T, Tabata Y, Domb AJ (2004) Dextran–spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection. Gene Ther 11:194–20310.1038/sj.gt.3302159 ↗
37. Hosseinkhani H, Inatsugu Y, Hiraoka Y, Inoue S, Shimokawa H, Tabata Y (2005a) Impregnation of plasmid DNA into 3-D scaffold and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells. Tissue Eng 11:1459–147510.1089/ten.2005.11.1459 ↗
38. Hosseinkhani H, Inatsugu Y, Hiraoka Y, Inoue S, Tabata Y (2005b) Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly (glycolic acid) fiber. Tissue Eng 11:1476–148810.1089/ten.2005.11.1476 ↗
39. Hosseinkhani H, Azzam T, Kobayashi H, Hiraoka Y, Shimokawa H, Domb AJ, Tabata Y (2006a) Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials 27:4269–427810.1016/j.biomaterials.2006.02.033 ↗
40. Hosseinkhani H, Kushibiki T, Matsumoto K, Nakamura T, Tabata Y (2006b) Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA–PEG engrafted cationized dextran complex and ultrasound irradiation. Cancer Gene Ther 13:479–48910.1038/sj.cgt.7700918 ↗
41. Hosseinkhani H, Yamamoto M, Inatsugu Y, Hiraoka Y, Inoue S, Shimokawa S, Tabata Y (2006c) Enhanced ectopic bone formation using combination of impregnation of plasmid DNA into 3-D scaffold and bioreactor perfusion culture. Biomaterials 27:1387–139810.1016/j.biomaterials.2005.08.017 ↗
42. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y (2006d) Osteogenic differentiation of mesenchymal stem cells in self assembled-peptide amphiphile nanofibers. Biomaterials 27:4079–408610.1016/j.biomaterials.2006.03.030 ↗
43. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y (2006e) Ectopic bone formation in collagen sponge-self assembled peptide amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor. Biomaterials 27:5089–509810.1016/j.biomaterials.2006.05.050 ↗
44. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H, Tabata Y (2006f) Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 27:5836–584410.1016/j.biomaterials.2006.08.003 ↗
45. Hosseinkhani H, Hosseinkhani M, Kobayashi H (2006g) Proliferation and differentiation of mesenchymal stem cells by using self assembly of peptide-amphiphile nanofibers. Biomed Mater 1:8–1510.1088/1748-6041/1/1/002 ↗
46. Hosseinkhani H, Hosseinkhani M, Kobayashi H (2006h) Design of tissue engineered nanoscaffold through self assembly of peptide amphiphile. J Bioact Compat Polym 21:277–29610.1177/0883911506066934 ↗
47. Hosseinkhani H, Hosseinkhani M, Khademhosseini A (2006i) Emerging applications of hydrogels and microscale technologies in drug discovery. Drug Discov 1:32–34
48. Hosseinkhani H, Hosseinkhani M, Khademhosseini A (2006j) Tissue regeneration through self-assembled peptide amphiphile nanofibers. Yakhte Med J 8:204–209
49. Hosseinkhani H, Kobayashi H, Tabata Y (2006k) Design of tissue-engineered nano-scaffold using peptide-amphiphile for regenerative medicine. Pept Sci 2005:341–344
50. Hosseinkhani H, Kobayashi H, Tabata Y (2006l) Selective differentiation cardiomyocyte cells by using peptide-amphiphile nanofibers. Pept Sci 2005:63–66
51. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y (2007a) Bone regeneration on a collagen sponge-self assembled peptide-amphiphile nanofibers hybrid scaffold. Tissue Eng 13:1–910.1089/ten.2006.0120 ↗
52. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H (2007b) Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release 117:380–38610.1016/j.jconrel.2006.11.018 ↗
53. Hosseinkhani M, Hosseinkhani H, Khademhosseini A, Bolland F, Kobayashi H, Prat S (2007c) Bone morphogenetic protein-4 enhances cardiomyocytes differentiation of cynomolgus monkey ES cells in knockout serum replacement medium. Stem Cells 25:571–58010.1634/stemcells.2006-0225 ↗
54. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Gabrielson NP, Pack DW, Kobayashi H (2008) DNA nanoparticles encapsulated in 3-D tissue engineered scaffold enhance osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A 85:47–6010.1002/jbm.a.31327 ↗
55. Hosseinkhani H, Hosseinkhani M, Vasheghani E, Nekoomanesh M (2009) In vitro sustained release and degradation study of biodegradable poly (d,l-lactic acid) microspheres loading theophylline. Adv Sci Lett 2:70–7710.1166/asl.2009.322 ↗
56. Hosseinkhani H, Hosseinkhani M, Hattori S, Matsuoka R, Kawaguchi N (2010) Micro and nanoscale in vitro 3D culture system for cardiac stem cells. J Biomed Mater Res A 94:1–810.1002/jbm.a.32676 ↗
57. Hosseinkhani H, Hosseinkhani M, Chen YR, Subramani K, Domb AJ (2011a) Innovative technology of engineering magnetic DNA nanoparticles for gene therapy. Int J Nanotechnol 8:724–73510.1504/IJNT.2011.041441 ↗
58. Hosseinkhani M, Hosseinkhani H, Chen YR, Subramani K (2011b) In vitro physicochemical evaluation of DNA nanoparticles. Int J Nanotechnol 8:736–74810.1504/IJNT.2011.041442 ↗
59. Hosseinkhani H, Hong PD, Yu DS, Chen YR, Farber IV, Domb AJ (2012) Development of 3D in vitro platform technology to engineer mesenchymal stem cells. Int J Nanomed 7:3035–304310.2147/IJN.S30434 ↗
60. Hosseinkhani H, Chen YR, He W, Hong PD, Yu DS, Domb AJ (2013a) Engineering of magnetic DNA nanoparticles for tumor-targeted therapy. J Nanopart Res 15:1–10
61. Hosseinkhani H, Hong PD, Yu DS (2013b) Self-assembled proteins and peptides for regenerative medicine. Chem Rev. doi: 10.1021/cr300131h
62. Hosseinkhani H, Hiraoka Y, Li CH, Chen YR, Yu DS, Hong PD, Ou KL (2013c) Engineering 3D collagen–IKVAV matrix to mimic neural microenvironment. ACS Chem Neurosci. doi: 10.1021/cn400075h
63. Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J (2006) RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Mol Ther 14:476–48410.1016/j.ymthe.2006.04.010 ↗
64. Jo J, Okazaki A, Nagane K, Yamamoto M, Tabata Y (2010) Preparation of cationized polysaccharides as gene transfection carrier for bone marrow-derived mesenchymal stem cells. J Biomater Sci Polym Ed 21:185–20410.1163/156856209X415495 ↗
65. Kalhor HR, Shahin F, Fouani MH, Hosseinkhani H (2011) Self-assembly of tissue transglutaminase into amyloid-like fibrils using physiological concentration of Ca2+. Langmuir 27:10766–1078410.1021/la200740h ↗
66. Kaneo Y, Ueno T, Tanaka T, Iwase H, Yamaguchi Y, Uemura T (2000) Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats. Int J Pharm 201:59–6910.1016/S0378-5173(00)00405-1 ↗
67. Kaneo Y, Tanaka T, Nakano T, Yamaguchi Y (2001) Evidence for receptor-mediated hepatic uptake of pullulan in rats. J Control Release 70:365–37310.1016/S0168-3659(00)00368-0 ↗
68. Khan W, Hosseinkhani H, Ickowicz D, Hong PD, Yu DS, Domb AJ (2012) Polysaccharide gene transfection agents. Acta Biomater 8:4224–423210.1016/j.actbio.2012.09.022 ↗
69. Kircheis R, Schuller S, Brunner S, Ogris M, Heider KH, Zauner W, Wagner E (1999) Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1:111–12010.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y ↗
70. Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, Wagner E (2001) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8:28–4010.1038/sj.gt.3301351 ↗
71. Konishi M, Tabata Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, Mandai M, Takakura K, Fujii S (2005) In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 103:7–1910.1016/j.jconrel.2004.11.014 ↗
72. Krebs MD, Salter E, Chen E, Sutter KA, Alsberg E (2010) Calcium phosphate–DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J Biomed Mater Res A 92:1131–113810.1002/jbm.a.32441 ↗
73. Lasic DD (1997) Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo. J Control Release 48:203–22210.1016/S0168-3659(97)00045-X ↗
74. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM (2000) Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 7:2023–202710.1038/sj.gt.3301339 ↗
75. Ledley FD (1995) Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 6:1129–114410.1089/hum.1995.6.9-1129 ↗
76. Lindstrom S, Iles A, Persson J, Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Lindstrom H, Andersson H (2010) Nanoporous titania coating of microwell chips for stem cell culture and analysis. J Biomech Sci Eng 5:272–27910.1299/jbse.5.272 ↗
77. Liu Y, Mounkes LC, Liggitt HD, Brown CS, Solodin I, Heath TD, Debs RJ (1997) Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 15:167–17310.1038/nbt0297-167 ↗
78. Louise C (2006) Nonviral vectors. Methods Mol Biol 333:201–226
79. Lungwitz U, Breunig M, Blunk T, Gopferich A (2005) Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 60:247–26610.1016/j.ejpb.2004.11.011 ↗
80. Luo D, Saltzman WM (2000) Synthetic DNA delivery systems. Nat Biotechnol 18:33–3710.1038/71889 ↗
81. Madry H, Cucchiarini M, Stein U, Remberger K, Menger MD, Kohn D, Trippel SB (2003) Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system. J Gene Med 5:502–50910.1002/jgm.368 ↗
82. Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay WS, Subramani K, Laurent S (2011) Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 111:253–28010.1021/cr1001832 ↗
83. Mohageri S, Hosseinkhani H, Ebrahimi NG, Solimani M, Kajbafzadeh AM (2010) Proliferation and differentiation of mesenchymal stem cell on collagen sponge reinforced with polypropylene/polyethylene terephathalate blend fibers. Tissue Eng Part A 16:3821–383010.1089/ten.tea.2009.0520 ↗
84. Mohammad-Taheri M, Vasheghani-Farahani E, Hosseinkhani H, Shojaosadati SA, Soleimani M (2012) Fabrication and characterization of a new MRI contrast agent based on a magnetic dextran–spermine nanoparticle system. Iran Polym J 21:239–25110.1007/s13726-012-0027-0 ↗
85. Nishikawa M, Yamauchi M, Morimoto K, Ishida E, Takakura Y, Hashida M (2000) Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther 7:548–55510.1038/sj.gt.3301140 ↗
86. Ogawara K, Hasegawa S, Nishikawa M, Takakura Y, Hashida M (1999) Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands. J Drug Target 6:349–36010.3109/10611869908996842 ↗
87. Pathak A, Patnaik S, Gupta KC (2009) Polyethylenimine derived nanoparticles for efficient gene delivery. Nucleic Acids Symp Ser (Oxf) 53:57–5810.1093/nass/nrp029 ↗
88. Sarabi RS, Sadeghi E, Hosseinkhani H, Mahmoudi M, Kalantari M, Adeli M (2011) Polyrotaxane capped quantum dots as new candidates for Cancer diagnosis and therapy. J Nanostruct Polym Nanocomp 7:18–31
89. Smyth Templeton N (2002) Liposomal delivery of nucleic acids in vivo. DNA Cell Biol 21:857–86710.1089/104454902762053828 ↗
90. Stankovics J, Crane AM, Andrews E, Wu CH, Wu GY, Ledley FD (1994) Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. Hum Gene Ther 5:1095–110410.1089/hum.1994.5.9-1095 ↗
91. Subramani K, Hosseinkhani H, Khraisat A, Hosseinkhani M, Pathak Y (2009) Targeting nanoparticles as drug delivery systems for cancer treatment. Curr Nanosci 5:134–14010.2174/157341309788185406 ↗
92. Subramani K, Mathew R, Hosseinkhani H, Hosseinkhani M (2011) Bone regeneration around dental implants as a treatment for peri-implantitis: a review of the literature. J Biomim Biomater Tissue Eng 11:21–3310.4028/www.scientific.net/JBBTE.11.21 ↗
93. Subramani K, Pathak S, Hosseinkhani H (2012) Recent trend in diabetes treatment using nanotechnology. Dig J Nanomater Bios 7:85–95
94. Takai T, Ohmori H (1990) DNA transfection of mouse lymphoid cells by the combination of DEAE–dextran-mediated DNA uptake and osmotic shock procedure. Biochim Biophys Acta 1048:105–10910.1016/0167-4781(90)90029-2 ↗
95. Takei Y, Maruyama A, Ferdous A, Nishimura Y, Kawano S, Ikejima K, Okumura S, Asayama S, Nogawa M, Hashimoto M, Makino Y, Kinoshita M, Watanabe S, Akaike T, Lemasters JJ, Sato N (2004) Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan–glycocalyx. FASEB J 18:699–70110.1096/fj.03-0494fje ↗
96. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN (1997) Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15:647–65210.1038/nbt0797-647 ↗
97. Thakor DK, Teng YD, Tabata Y (2009) Neuronal gene delivery by negatively charged pullulan–spermine/DNA anioplexes. Biomaterials 30:1815–182610.1016/j.biomaterials.2008.12.032 ↗
98. Tian F, Hosseinkhani H, Estrada G, Kobayashi H (2007) Quantitative method for the analysis of cell attachment using the aligned scaffold structure. J Phys 61:587–590
99. Tian F, Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Yokoyama Y, Estrada G, Kobayashi H (2008) Quantitative analytical of cell adhesion on aligned micro- and nano-fibers. J Biomed Mater Res A 84:291–29910.1002/jbm.a.31304 ↗
100. Turgeman G, Pittman DD, Muller R, Kurkalli BG, Zhou S, Pelled G, Peyser A, Zilberman Y, Moutsatsos IK, Gazit D (2001) Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3:240–25110.1002/1521-2254(200105/06)3:3<240::AID-JGM181>3.0.CO;2-A ↗